IBO · Impact Biomedical Inc.

Substantial doubt about the company's ability to continue as a going concern.

“As reflected in the accompanying financial statements the Company has incurred operating losses as well as negative cash flows from operating activities over the past two years. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year of the date that the financial statements are issued.”